Public health increasingly uses unofficial signals such as rumors, media, search, and self-reported symptoms to detect emergencies before official counts. Commercial prediction markets, where people bet on disease events, are a candidate new source, built for forecasting; but the expectation they price is itself a further unofficial signal. Their use as a public health signal is unvalidated in this domain and ethically contested: no study has yet shown that these prices anticipate official indicators, and whether public health should read bets on disease at all is disputed. A 2026 study judged them poor forecasters, but accuracy and surveillance value differ. Using thirteen Kalshi markets, we describe what such a reading would involve (a watchlist, an implied distribution, and fast repricing) as a collective expectation signal adjacent to participatory surveillance, and we set out the validation and governance agenda that would have to precede any use.
No takes yet. Share an insight, caveat, or question.
Onicio Batista Leal Neto (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: